CLINICAL_TRIALS
trial_result
· 2022-06-22
Clinical Trial Update: A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 3]
Summary
Phase 3 trial of oral sapacitabine in elderly patients with newly diagnosed acute myeloid leukemia has completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cyclacel Pharmaceuticals, Inc. | Conditions: Acute Myeloid Leukemia | Phase 3 | Status: COMPLETED | Results posted: 2022-06-22